Longitudinal evaluation of proton magnetic resonance spectroscopy metabolites as biomarkers in Huntington's disease. (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/braincomms/fcac258

PubMed Identifier: 36382217

Publication URI: http://europepmc.org/abstract/MED/36382217

Type: Journal Article/Review

Volume: 4

Parent Publication: Brain communications

Issue: 6

ISSN: 2632-1297